Trial Profile
Bioanalysis of DCV/ASV in old patient(aged 76 years or older)infected with HCV: Pilot Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2016
Price :
$35
*
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- 28 Oct 2016 Status changed from active, no longer recruiting to completed.
- 31 Oct 2014 New trial record